NCT00000234View on ClinicalTrials.gov

Alternate Day Buprenorphine Administration, Phase XI - 16

PHASE2CompletedINTERVENTIONAL

0

Timeline

Start Date

Not specified

Conditions

Opioid-Related Disorders

Interventions

DRUG

Buprenorphine

Trial Locations (1)

05401

Treatment Research Center, Burlington

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Vermont

OTHER

NCT00000234 - Alternate Day Buprenorphine Administration, Phase XI - 16 | Biotech Hunter | Biotech Hunter